Skip to main content

Table 5 Logistic regression for death or disease progression at 12 months in patients with FVC ≥ 80%

From: Disease progression in idiopathic pulmonary fibrosis with mild physiological impairment: analysis from the Australian IPF registry

 

n

OR

95% CI

p

Age

216

0.99

0.94

1.05

0.847

male

216

0.86

0.35

2.09

0.739

BMI

212

1.00

0.92

1.10

0.954

Ever smoker

216

0.93

0.34

2.50

0.879

FVC % preda

216

0.81

0.56

1.16

0.241

DLco %preda

216

0.87

0.67

1.14

0.312

CPIa

216

1.26

0.86

1.86

0.234

GAP stage

216

1.12

0.43

2.90

0.813

6 MWDb

63

0.75

0.54

1.04

0.083

SpO2 at start

63

0.86

0.71

1.03

0.108

SpO2 at end

63

0.89

0.81

0.98

0.021

SpO2 nadir

59

0.89

0.81

0.98

0.024

SGRQc

199

1.02

0.93

1.12

0.688

UCSD SOBQa

126

1.00

0.77

1.28

0.970

Cough severitya

177

1.16

0.95

1.41

0.136

  1. BMI body mass index, FVC forced vital capacity, DLco diffusion capacity for carbon monoxide, CPI composite physiological index, GAP gender age physiology, 6MWD 6 min walk distance, SpO2 peripheral blood oxygen saturation, SGRQ St George’s Respiratory Questionniare, UCSD- SOBQ University of California San Diego shortness of breath questionnaire. aFor every 10 unit change; b for every 50 m change; c for every 4 point change